A support group for anyone affected by leukaemia to come together, share experiences...
Although we make every effort to ensure accuracy, Macmillan Cancer Support cannot accept liability for this information, or for third-party information such as other websites to which we link. If you are concerned about your health you should consult your doctor. Please bear in mind that your question can be read by others - don't post your contact details or any other information that could personally identify you. All answers will be based on information that is correct at the time of posting.
Did they started using this program under the NHS please?
I am sorry that it has taken so long to come back to you, my email notifications were down ( which i was unaware of!).
The CART program is only available for paediatrics at present on the NHS.
Hope this helps.
Caroline - Macmillan Information Nurse Specialist
Remember you can also speak with the Macmillan Support Line team of experts. Phone free on 0808 808 0000 (7 days a week, 8am-8pm) or by email.
In addition to the information Caroline has given you, the National Institute for Health and Care Excellence (NICE) has recently recommended Axicabtagene-ciloleucel (Yescarta) for use in adults with refractory or relapsed diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma. NICE has also recommended Tisagenlecleucel (Kymriah) for use in adults with relapsed or refractory diffuse large B-cell lymphoma. These are both now available for CAR-T therapy through the Cancer Drugs Fund in NHS England.
CAR T-cell therapy for these lymphoma patients will be available at seven NHS hospitals as the service is rolled out across the country. However, due to the high risks and complications associated with CAR-T therapy only a small number of patients will benefit from this treatment within NHS just now. There is more information on CAR-T therapy here.
The best person to discuss your suitability for this and any other treatment is your consultant haematologist.
I hope this information is helpful. If you have any further questions, please get in touch via email or phone. You can call us free from landlines and from most mobile phone networks* on 0808 808 00 00 Monday to Sunday 8am – 8pm.
Macmillan Information Nurse Specialist
I was at a conference last week and have more information for you on CART cells.
There are now 7 centres in the UK ready ( or have recently commenced) the CAR-T programme. They are UCH, Kings, University Bristol, Newcastle, The Christie, Manchester Royal Infirmary and QE in Birmingham. They will be giving the treatment for DLBCL patients only and are predict that they will treat up to 200 patients this year.
To see if you are eligible for such treatment, you need to discuss it carefully with your haematologist and then they need to refer you for assessment.
I hope this helps
Safe payments by:
We're here to provide physical, financial and emotional support. So whatever cancer throws your way, we're right there with you.
© Macmillan Cancer Support
© Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man
(604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company
number 2400969. Isle of Man company number 4694F. Registered office: 89 Albert Embankment, London SE1 7UQ. VAT no: